Ignite Creation Date:
2025-12-25 @ 1:02 AM
Ignite Modification Date:
2026-02-22 @ 1:33 PM
Study NCT ID:
NCT00614393
Status:
COMPLETED
Last Update Posted:
2018-08-08
First Post:
2008-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer (MK-0646-004)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-12-24
Start Date Type:
ACTUAL
Primary Completion Date:
2010-06-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-03-07
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-17
First Submit QC Date:
None
Study First Post Date:
2008-02-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-11-01
Results First Submit QC Date:
None
Results First Post Date:
2016-12-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-12
Last Update Post Date:
2018-08-08
Last Update Post Date Type:
ACTUAL